THERE IS
ONLY ONE
ST. JUDE
2012 ANNUAL REPORT
THERE IS ONLY ONE ST. JUDE
The mission of St. Jude Children’s
Research Hospital is to find cures
for children with cancer and other
deadly diseases through research
and treatment. St. Jude is dedicated
to the belief of our founder that “no
child should die in the dawn of life.”
FINDING CURES.
SAVING CHILDREN.
THOMAS FAMILY LETTER 7
EXECUTIVE MESSAGES 8
EXCEPTIONAL CARE 10
PIONEERING RESEARCH 18
A GLOBAL LEADER ALSAC is the fundraising and
awareness organization for St. Jude.
ALSAC’s sole mission is to raise the
funds and awareness necessary to
operate and maintain St. Jude.
Bailey | at age 5
Wilms tumor
3
26
FUNDRAISING 34
LEADERSHIP
AND SERVICE 42
FINANCIAL HIGHLIGHTS 53
FINDING CURES. SAVING CHILDREN.
Brooklynn | at age 4
acute lymphoblastic leukemia
St. Jude Children’s Research Hospital® is leading the way the world
understands, treats and defeats childhood cancer and other deadly
diseases. We’re the place where doctors send their toughest cases,
because St. Jude has the world’s best survival rates for the most
aggressive forms of childhood cancers. We create more clinical trials
for cancer than any other children’s hospital and turn laboratory
discoveries into lifesaving treatments that benefit patients – every day.
St. Jude freely shares the discoveries we make, and every child saved
at St. Jude means doctors and scientists can use that knowledge to
save thousands more children around the world.
“St. Jude is a wonderful place. We love our doctor. He’s so
warm and comforting. Brooklynn loves the playrooms
and her nurses, too.”
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
— Rebecca, mother of Brooklynn
PAGE 2
Unlike any other hospital, the majority of funding
for St. Jude comes from public contributions.
Thanks to generous donors, families never receive
a bill from St. Jude for treatment, travel, housing
or food, because all a family should worry about is
helping their child beat these deadly diseases.
To learn how you can help St. Jude in finding cures and saving children,
visit stjude.org.
Izarah | at age 5
acute lymphoblastic leukemia
There are great hospitals and
great research institutions.
St. Jude is both.
That is our strength. We find
cures and save children’s lives.
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 4
Dear Friends,
In 2012, we celebrated a milestone at St. Jude Children’s Research Hospital – 50 years of
finding cures and saving children. And all because one man’s dream became the mission
of millions.
That man was our father, Danny Thomas, who dared to believe that, together, we could make a
difference – that we could battle deadly diseases like cancer that take precious young lives – and
that we could win.
With your help, our father opened St. Jude Children’s Research Hospital to the desperately
ill children of the world. Today, we can see how the research discoveries and new treatment
breakthroughs at St. Jude are helping children to live. And we know that as our scientists
continue their work, tomorrow could bring the next cure – and hope to families everywhere.
As we look back at 2012, there is much to be thankful for – especially for the many good friends
like you who helped us celebrate the 50th anniversary and lifesaving mission of St. Jude.
You continue to show an incredible level of support and commitment. And we share our deepest
gratitude for the triumph of that mission: the beautiful children who, because of the pioneering
research and exceptional care at St. Jude, have the chance to live long and healthy lives.
Our father dared to dream of a day when no child would die in the dawn of life. With your
continued support, we can make that dream a reality.
God bless the children,
Marlo, Terre and Tony Thomas
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 6
A lifetime of moments.
Think about that – moments of laughter and learning, moments of playing
and growing up. That is what we wish for every child and for the families who
love them, and that is why we are so thankful for everyone who supports the
lifesaving mission of St. Jude Children’s Research Hospital.
That support means hope for a lifetime
of moments for children everywhere.
The commitment of our donors, volunteers, celebrity and corporate partners –
everyone who has ever donated $1 or an hour of their time – truly makes a
difference. Because of that commitment, no family will ever receive a bill
from St. Jude. The funds and awareness raised for St. Jude are helping our
doctors and scientists find cures that will save children’s lives, and ensure
that St. Jude continues to meet the needs of our patients and their families.
That is why the generosity of each person who supports St. Jude is so
important. Critically ill children need our help if they are to have a chance at
a lifetime of moments.
Compassion. Innovation.
Collaboration. Quality.
St. Jude Children’s Research Hospital brings these qualities to life every
day through the pioneering research and exceptional care that is the hallmark
of St. Jude.
Since the hospital opened in 1962, public support for St. Jude has fueled our
success in changing the way the world treats childhood cancer. This support
makes it possible for our scientists to follow every encouraging path that could
lead to cures. Our doctors can do everything possible for every patient without
regard for the cost of treatment. We provide the resources and working
environment that attracts the brightest scientists, doctors and staff, who
bring their very best to the fight against deadly childhood diseases.
And the discoveries made at St. Jude are the world’s discoveries – freely
shared so that researchers around the globe have the information that
could help advance scientific knowledge, so that doctors in communities
everywhere can use the latest treatments to help cure a sick child.
St. Jude will continue on our quest to improve survival rates for childhood
cancer and other deadly diseases.
We will not stop until we reach 100%.
We are working toward the day when childhood cancer is no longer a threat
to a long and healthy life.
Richard Shadyac Jr.
CEO
ALSAC, the fundraising and
awareness organization for St. Jude
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 8
Dr. William E. Evans
Director and CEO
St. Jude Children’s Research Hospital
Delancy | at age 4
sickle cell disease
“At St. Jude, we know we are
not just treating a disease.
We’re treating a child.”
— Pam Dotson, RN, MBA
Senior Vice President, Patient Care Services
Chief Nursing Officer
EXCEPTIONAL CARE
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 10
Alyssa | at age 2
EXCEPTIONAL CARE
adrenocortical carcinoma
PUTTING PATIENTS AND FAMILIES FIRST
St. Jude scientists and doctors work around the clock to find the cures
that will save children’s lives. At the same time, an experienced team
of health care professionals is putting the care of our patients and their
families above all else.
We understand how hard it can be for patients
and their families to cope with the diagnosis of
a life-threatening disease like cancer.
“We didn’t know if she would come out of this walking, talking,
smiley and happy, but she has. She’s not as strong as she was,
but she’s getting better all the time. One of the great things about
St. Jude is that they pay attention to these things. At St. Jude, they
don’t wait until there’s a serious problem to intervene quickly.”
— Patty, mother of Alyssa
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 12
From a patient’s very first day at St. Jude, our dedicated staff mobilizes
to support the family with exceptional care. Families never receive a bill
from St. Jude for treatment, travel, housing or food – because all a
family should worry about is helping their child live.
We do everything we can for every patient.
EXCEPTIONAL CARE
ALWAYS ON THE CUTTING EDGE
St. Jude provides our patients with the best and most advanced treatments
possible, and your support enables our scientists and doctors to continue
improving treatments and survival rates in state-of-the-art facilities.
WE ARE BUILDING THE NATION’S FIRST
PROTON THERAPY CENTER THAT WILL BE
SOLELY DEDICATED TO TREATING CHILDREN.
THE TOWER WILL ALSO INCLUDE:
Thanks to you, we broke ground in FY12 on a new tower located
in the heart of our campus designed to help advance our growing
research and treatment and save more children’s lives.
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 14
NEW AND
EXPANDED
SURGERY
SUITES
A STATE OF
THE ART
INTENSIVE
CARE UNIT
A GLOBAL
EDUCATION &
COLLABORATION
CENTER
TREATMENTS INVENTED AT ST. JUDE
HAVE HELPED PUSH THE OVERALL
CHILDHOOD CANCER SURVIVAL
RATE FROM 20% TO MORE THAN
80% SINCE WE OPENED IN 1962.
OUR DOCTORS AND SCIENTISTS ARE
WORKING TO PUSH THAT SURVIVAL
RATE UP TO 90%—AND BEYOND.
1962 – PRESENT *
5-YEAR CANCER SURVIVAL RATES
ACUTE LYMPHOBLASTIC
LEUKEMIA**
4% TO 94%
HODGKIN LYMPHOMA
50% TO 95%
RETINOBLASTOMA
ST. JUDE HAS
TREATED PATIENTS
FROM ALL 50 STATES AND
AROUND THE WORLD.
75% TO 95%
NEUROBLASTOMA
10% TO 75%
OSTEOSARCOMA
20% TO 70%
*Based on national averages from 2001-2007
**Reflects survival rate at St. Jude, the highest worldwide for ALL
ST. JUDE FREELY SHARES THE BREAKTHROUGHS IT MAKES,
AND EVERY CHILD SAVED AT ST. JUDE MEANS DOCTORS
AND SCIENTISTS CAN USE THAT KNOWLEDGE TO SAVE
THOUSANDS MORE CHILDREN.
“Communication and teamwork are
important here at St. Jude. When I
visit other places to explain our
research, I talk not only of the close
distance between the buildings that
allows us to bridge clinical and basic
research, but I talk about the value
of collaboration.”
— Hiroto Inaba, MD, PhD
St. Jude Oncology
PIONEERING RESEARCH
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 18
EQUAL ACCESS IMPROVES SURVIVAL RATES
PIONEERING RESEARCH
SAVING PRECIOUS LIVES
Equal access to care at St. Jude helped close the
survival gap for young African-American cancer
patients. While racial disparities in childhood
cancer survival rates continue nationwide, a
St. Jude study suggested that equal access to care
results in equally good outcomes.
Our doctors and scientists are
leading the way in finding new
treatments that will save even
more lives.
We’re discovering how cancer affects different
populations, solving the mysteries of how
certain drugs and targeted therapies work,
finding ways to improve treatments and
reduce side effects, and unlocking the secrets
of how cells become cancerous.
Aniya | at age 3
pineoblastoma
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 20
St. Jude researchers used a new
strategy that could speed drug
development for rare childhood
cancers. This pioneering approach
identified dozens of potential new
treatments for an aggressive brain
tumor that affects children.
JOURNAL OF CLINICAL ONCOLOGY | APRIL 2012
CANCER CELL | SEPTEMBER 2011
REDUCING RADIATION
A GUARD AGAINST
TUMORS
STUDY FINDS
LEUKEMIA RISK
St. Jude discovered a protein’s
role in preventing the development
of brain tumors. Protein TopBP1
is known to play a vital role in
brain development, but St. Jude
researchers found it also guards
early brain cells from DNA
damage that leads to cancer.
A St. Jude-led study linked gene
variation to an increased risk of
developing childhood leukemia
and relapse. Inherited risk factors
for acute lymphoblastic leukemia
are more common in Hispanic
patients and findings from this
study offer important clues for
increasing survival rates.
NATURE NEUROSCIENCE
APRIL 2012
JOURNAL OF CLINICAL ONCOLOGY
JANUARY 2012
St. Jude made progress in the
quest to reduce radiation in the
treatment of young Hodgkin
lymphoma patients. A St. Jude-led
study that omitted radiation
succeeded in maintaining survival
rates while reducing chances of
treatment side effects, including
the risk of second cancers.
For more information about the pioneering
research and scientific breakthroughs at
St. Jude Children’s Research Hospital,
please see the St. Jude Scientific Report at
stjude.org/stjudepublications.
NEW APPROACH TO
DRUG DEVELOPMENT
JOURNAL OF THE AMERICAN
MEDICAL ASSOCIATION | JUNE 2012
PIONEERING RESEARCH
REVEALING CANCER’S SECRETS
In 2010, we launched the St. Jude Children’s Research Hospital—
Washington University Pediatric Cancer Genome Project. Our efforts
will show scientists things they’ve never been able to see before about how
cancer begins and grows in a child. Before this project began, no child’s
genome – the complete set of instructions needed to assemble and
sustain life – had ever been sequenced. So far, St. Jude has sequenced
the complete normal and cancer genomes of more than 700 children
and teens with aggressive and challenging cancers.
OUR PEDIATRIC CANCER
GENOME
PROGRAM, THE LARGEST
IN THE WORLD, WILL
HELP TRANSFORM
THE WAY CHILDHOOD
CANCER IS TREATED
WORLDWIDE.
GENOME DATA
WE FREELY SHARED
MORE THAN
DOUBLED
THE AMOUNT OF
INFORMATION
AVAILABLE FROM ALL
HUMAN GENOME
SOURCES COMBINED.
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 22
A SPECIAL GENOME
DATA WEBSITE
GIVES SCIENTISTS
WORLDWIDE
EASY ACCESS TO
INFORMATION NOT
AVAILABLE
ANYWHERE ELSE.
ST. JUDE DISCOVERIES
FROM THE GENOME
PROJECT ARE HELPING
DOCTORS AND
SCIENTISTS WORLDWIDE:
• Discovered genetic mistakes at the
heart of a rare, lethal type of childhood
leukemia. Nature | January 2012
• Discovered why retinoblastoma develops
so rapidly, allowing identification of an
anti-cancer agent that might be an
effective treatment. Nature | January 2012
• Discovered that 78 percent of patients
battling an aggressive type of brain
tumor had changes in two genes not
previously linked to cancer.
Nature Genetics | January 2012
• Discovered a gene mutation that may help
explain the connection between an often
fatal form of neuroblastoma and the child’s
age at diagnosis. Journal of the American
Medical Association | March 2012
• Discovered genetic mistakes in three
subtypes of medulloblastoma–the most
common type of childhood brain tumor–
that might be targeted with drugs already
in development. Nature | June 2012
“This effort has generated
more discoveries than we
thought possible.”
— James Downing, MD
St. Jude Deputy Director, Scientific Director and
Executive Vice President
ST. JUDE IS THE
EPICENTER
FOR THE LATEST
NEARLY EVERY
PEDIATRIC CANCER
SURGEON IN THE
U.S. AND CANADA
PARTICIPATES IN
TRAINING AT ST. JUDE.
INNOVATIONS
IN RESEARCH AND
TREATMENT
FOR CHILDHOOD
CANCERS.
ST. JUDE CREATES
MORE CLINICAL
TRIALS FOR CANCER
THAN ANY OTHER
CHILDREN’S HOSPITAL.
ST. JUDE
SHARED OUR RESEARCH RESULTS
IN 775
ARTICLES PUBLISHED IN
PEER-REVIEWED JOURNALS IN 2012.
THAT EQUALS {ON AVERAGE}
A NEW DISCOVERY SHARED EVERY
11 HOURS.
“The St. Jude International
Outreach Program is like
lighting a candle from one
flame. It allows us to spread
that light all over the world.”
— Sima Jeha, MD
St. Jude Oncology
Isabella | at age 5
rhabdomyosarcoma
A GLOBAL LEADER
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 26
A GLOBAL LEADER
SAVING THE WORLD’S CHILDREN
St. Jude freely shares the breakthroughs it makes, and every child saved
at St. Jude means doctors and scientists worldwide can use that knowledge
to save thousands more children. But we also extend our commitment to
helping children beyond our walls through our International Outreach
Program, Cure4Kids.org and the St. Jude Domestic Affiliates Program.
INTERNATIONAL OUTREACH
Claire | at age 3
optic pathway glioma
“We’re constantly reminded about why we’re doing this work. Every
day we see children and families who are affected by these terrible
diseases. It’s strong motivation to do work that will provide
important basic scientific insights, ultimately benefiting patients
and improving treatment of children worldwide.”
– Charles Mullighan, MD, MBBS, St. Jude Pathology
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 28
There are about 175,000 new cases of childhood cancer diagnosed
worldwide every year, and more than 70 percent of the world’s children with
cancer do not have access to modern treatment. St. Jude is leading the
way in helping to improve diagnosis, treatment and, ultimately, the
survival rates of these children.
Through the St. Jude International Outreach Program, we are sharing our
clinical knowledge, technology and organizational expertise with other
health care professionals around the world. And we’re working with local
organizations in these countries to teach them how to raise funds critical to
improving their treatment and care.
A GLOBAL LEADER
CURE4KIDS.ORG
CURE4KIDS.ORG
FREE TO PEDIATRIC
SHARING OUR RESEARCH
HEALTH CARE
St. Jude is connecting health care professionals around the globe in
the fight against childhood cancer and other deadly diseases through
Cure4Kids.org, a comprehensive online educational and collaboration
program. This innovative website gives doctors everywhere a free and
open meeting place online.
PROFESSIONALS, SCIENTISTS
AND RESEARCHERS.
MORE THAN
Our laboratories might not be in your communities,
but our discoveries are.
2,100
DOMESTIC AFFILIATES
SEMINARS AVAILABLE
Through the St. Jude Domestic Affiliates Program, we are serving children
at six clinic sites in five states. Learn more about our affiliates program at
stjude.org/domestic-affiliates.
USED BY MORE THAN
34,000 HEALTH CARE
Baton Rouge, LA | Johnson City, TN | Peoria, IL
Shreveport, LA | Springfield, MO | Huntsville, AL
PROFESSIONALS FROM
A’Shai | at age 1
sacrococcygeal germ cell tumor
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 30
185 COUNTRIES.
GUATEMALA CITY
SURVIVAL RATES FOR CHILDHOOD CANCER
HAVE INCREASED FROM 28% TO 70%. THE
RATE OF ABANDONMENT OF TREATMENT
HAS DECREASED FROM 42% TO 2.5%.
BEIJING, CHINA
THE GLOBAL IMPACT OF ST. JUDE
MORE THAN
17,000 PATIENTS
TREATED ANNUALLY
AT ST. JUDE INTERNATIONAL
PARTNER SITES
SURVIVAL RATES FOR ACUTE LYMPHOBLASTIC
LEUKEMIA HAVE INCREASED FROM 50%
TO 90%. THE RATE OF ABANDONMENT OF
TREATMENT HAS DECREASED FROM 50%
TO CLOSE TO ZERO.
EL SALVADOR
SURVIVAL RATES FOR CHILDREN WITH
ACUTE LYMPHOBLASTIC LEUKEMIA WENT
FROM 10% TO 60% AND ARE NOW
APPROACHING INTERNATIONAL STANDARDS.
RECIFE, BRAZIL
20 PARTNER
SITES IN
14 COUNTRIES
SURVIVAL RATES FOR CHILDHOOD CANCERS
WENT FROM 29% TO 70%.
Learn more about the St. Jude International Outreach Program
at stjude.org/international.
Allison | at age 9
medulloblastoma
“I don’t know what I would have
done without St. Jude. There was
so much help — with housing,
transportation and groceries.
I never worried about the cost
with any of those things.”
— Tabitha, mother of Allison
FUNDRAISING
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 34
$1.8
MILLION
Ian | at age 5
medulloblastoma
2
DAILY
OPERATING
COST
ND
LARGEST
HEALTHCARE
CHARITY
IN THE U.S.
Because the majority of funding comes from public contributions,
St. Jude has the freedom to focus on what matters most — saving
kids regardless of their financial situation.
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 36
28
1,000
CORPORATE
PARTNERS
#1 CHARITY
IN SOCIAL MEDIA
OF OPERATING
FUNDS RAISED BY
PRIVATE
DONATIONS
FORTUNE
EMERGING AS
75%
8.8
MILLION
ACTIVE DONORS
31 REGIONAL
FUNDRAISING
OFFICES
Iyah | at age 3
neuroblastoma
Thank you for all that you do for the children
of St. Jude.
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 38
Millions of people from all walks of life
have embraced the mission of St. Jude to find
cures that save the lives of children. Toddlers
ride tricycles, athletes run and swim and
pedal for miles, and young people write
hundreds of letters asking for support. At
thousands of events – from golf tournaments
to galas – people passionately raise funds
and awareness to help the kids of St. Jude.
And they generously give – from one-time
and monthly donations to legacy gifts – to
bring hope to families everywhere.
HOLDING BAKE SALES & LEMONADE STANDS
SHOPPING & BUYING SPECIALTY MERCHANDISE
RIDING TRICYCLES & MOTORCYCLES
GOLF & SHOOTING BASKETS
PLAYING
WALKING &
Your continued support helps sustain
our lifesaving mission.
RUNNING &
PURCHASING PINUPS & TICKETS TO WIN HOUSES
HOSTING DINNERS & ANNUAL GALAS
TO JOIN OUR MISSION, VISIT STJUDE.ORG/WAYSTOHELP.
DASHING THROUGH MUD & FIRE
GIVING MONTHLY & THROUGH PAYROLL DEDUCTION
WORKING MATH PROBLEMS & WRITING LETTERS
TWEETING & BLOGGING & LIKING US ON FACEBOOK
MAKING TRIBUTES & LASTING LEGACY GIFTS
F
“This is a sacred cause. I mean this is
a very, very important thing we do
here, and that is to save the lives of
innocent children — not just here,
but everywhere.”
– Stephen Camer MD
Member of ALSAC/St. Jude Boards of Directors and Governors
Former Chairman of the St. Jude Board of Governers
Kaelyn | at age 7
acute lymphoblastic
leukemia
LEADERSHIP AND SERVICE
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 42
LEGACY OF SERVICE
The members of the ALSAC/
St. Jude Boards of Directors
and Governors are volunteers
from throughout the
United States who serve
without compensation.
Many represent the second and third
generations of their families to support
St. Jude through service on the Board.
An honorary body of emeritus members
recognizes distinguished service on the
Board by those who cannot continue to
actively participate.
Angie | at age 11
medulloblastoma
FY12 ALSAC BOARD OF
DIRECTORS OFFICERS
Sheryl A. Bourisk
Partner/Producer
Robert T. Molinet
Corporate Vice President
EMERITUS MEMBERS
Camille F. Sarrouf Jr.
Attorney
Chairman/President
Stephen J. Camer, MD
Surgeon
James O. Naifeh Jr.
Business
Thomas G. Abraham
CEO
Anthony “Tony” Charaf
Business
Helen Nugent
Banking
Jack A. Belz
Real Estate
Ann M. Danner
Real Estate Developer
Ramzi Nuwayhid
Financial Advisor
V. Reo Campian
Manufacturing (Retired)
Michael Francis
Retail
Thomas J. Penn III
NBA Administration
Joseph G. Cory, PhD
Professor of Biochemistry (Retired)
Fred P. Gattas III
Nuclear Pharmacist and
Corporate Pharmacy Quality Manager
Camille F. Sarrouf
Attorney
Leslie Dale
Communications (Retired)
Joseph G. Shaker
Advertising
Lewis R. Donelson III
Attorney
George A. Simon II
Manufacturing
Edward M. Eissey, PhD
Educator (Retired)
Paul J. Simon
Manufacturing
Hasan M. El Khatib
Pharmaceuticals
Pat Kerr Tigrett
Designer
Terre Thomas
Writer
George Elias Jr.
Attorney
Robert P. Younes, MD
Physician
Tony Thomas
Producer
Sam F. Hamra
Attorney
IN MEMORIAM
Paul H. Wein
Attorney
Theodore Hazer
Broker (Retired)
Thomas C. Wertz
Finance
Joseph G. Hyder
Broadcasting
Ramzi T. Younis, MD
Physician
Joseph D. Karam
Wendy’s Franchise Owner
Tama Zaydon
Investments
Richard J. Karam
Attorney
William E. Evans, PharmD.
Director/CEO
St. Jude Children’s Research Hospital
James A. Kinney
Banking (Retired)
EXECUTIVE ADMINISTRATOR
TO THE BOARD
Richard M. Unes
Construction
First Vice Chair
Paul J. Ayoub
Attorney
Second Vice Chair
Fred R. Harris
Manufacturing
Secretary
FY12 ST. JUDE BOARD OF
GOVERNORS OFFICERS
Robert A. Breit, MD
Radiologist
Chairman/President
Terry Burman
Retail (Retired)
First Vice Chair
Martha Perine Beard
Banking
Second Vice Chair
Fred P. Gattas Jr.
Business
Secretary
FY12 MEMBERS
Joyce Aboussie
Public Relations
Susan Mack Aguillard, MD
Pediatrician
Mahir R. Awdeh, MD
Cardiologist
Joseph S. Ayoub Jr.
Attorney
James B. Barkate
Real Estate/Title Research
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 44
Christopher B. George, MD
Physician
Judy A. Habib
Marketing
Gabriel Haddad, MD
Pediatrician
Paul K. Hajar
Publishing
Charles C. Hajjar
Real Estate
Fouad Hajjar, MD
Pediatrician
Bruce B. Hopkins
Banking
Richard Leyoub
Attorney
Salli LeVan
Business Consultant
Paul J. Marcus
Investments
Michael McCoy
Sheriff
(NON-VOTING MEMBERS
OF THE BOARD)
Judy Lester
Business (Retired)
Albert W. Lian
Attorney (Retired)
Donald G. Mack, MD
Pediatrician
George M. Maloof
Attorney (Retired)
Speaker James O. Naifeh
Government
David B. Nimer
Export-Import
Talat M. Othman
Investments
Edward W. Reed, MD
Physician (Retired)
Manal Saab
Business
Frederick W. Smith
Aviation Transportation
Ronald Terry
Investments (Retired)
Peter J. Decker Jr.
Attorney
Jim A. Maloof
Real Estate
EX-OFFICIO VOTING MEMBERS
Richard C. Shadyac Jr.
CEO, ALSAC
Helen B. Wood
ALSAC/St. Jude Boards
EPSILON SIGMA ALPHA
Susan Winters
ESA President
(Non-elected member)
SCIENTIFIC ADVISORY BOARD
The Scientific Advisory Board is an autonomous panel
of renowned physicians and scientists.
They help foster the medical and scientific development of St. Jude
by discussing ongoing and potential research projects with faculty members,
reporting to the Board of Governors on institutional policy and oversight and
advising the hospital director and scientific director on policy decisions,
appointments, research directions and clinical activities.
CHAIR
Todd R. Golub, MD
Director, Cancer Program
Howard Hughes Medical Institute Investigator
Broad Institute of MIT and Harvard
Professor of Pediatrics
Harvard Medical School
VICE CHAIR
Theodore S. Lawrence, MD, PhD
Isadore Lampe Professor and Chair
Department of Radiation Oncology
University of Michigan Medical School
MEMBERS
Valerie P. Castle, MD
Ravitz Professor of Pediatrics and Communicable Diseases
Chair, Department of Pediatrics
Physician-in-Chief, C.S. Mott Children’s Hospital
University of Michigan Health System
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
David S. Eisenberg, PhD
Howard Hughes Medical Institute Investigator
Director, UCLA-DOE Institute for Genomics
and Proteomics
Department of Biological Chemistry
University of California-Los Angeles
Marilyn J. Hockenberry, PhD
Professor, Duke University School of Nursing
Chair, Institutional Review Board
Duke University
William G. Kaelin Jr., MD
Professor of Medicine
Howard Hughes Medical Institute Investigator
Dana-Farber Cancer Institute and
Harvard Medical School
Michael P. Link, MD
The Lydia J. Lee Professor of Pediatrics
Stanford University School of Medicine
|
PAGE 46
Eric G. Pamer, MD
Chief, Infectious Disease Service
Enid A. Haupt Chair in Clinical Investigation
Memorial Sloan-Kettering Cancer Center
Charles L. Sawyers, MD
Chair, Human Oncology and Pathogenesis
Memorial Sloan-Kettering Cancer Center
Robert Shamberger, MD
Chief, Department of Surgery
Boston Children’s Hospital
Paul M. Sondel, MD, PhD
Walker Professor, Division Head
University of Wisconsin
Louise C. Strong, MD
Sue and Radcliffe Killam Chair
Professor of Cancer Genetics
University of Texas M.D. Anderson Cancer Center
Cody | at age 10
Ewing sarcoma
FUNDRAISING
GUIDANCE
The volunteers who serve on the
Professional Advisory Council
and the ALSAC Leadership
Council are leaders and experts
in their fields who generously
give their time and talents to
support ALSAC’s fundraising and
awareness efforts for St. Jude.
The councils meet regularly in Memphis
and in teleconferences to provide
guidance on strategic fundraising issues
and ways to raise awareness for the
St. Jude mission.
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 48
FY12 PROFESSIONAL ADVISORY COUNCIL
FY12 ALSAC LEADERSHIP COUNCIL
John M. Engquist
H & E Equipment Services LLC
Scott Nietschmann
SNL Restaurant Ventures
Marilyn Aboussie
Chief Justice (Retired)
Charles A. Feghali
Creative Fuels
Duncan Williams
Duncan-Williams Inc.
Amin J. Barakat
Physician/Clinical Professor of Pediatrics
Georgia Hobaica Frasch
Philanthropist
William C. Perez
Adams and Reese LLP
Nick J. Rahall
U.S. House of Representatives
Craig Witsoe
Abound Solar
Romero Britto
Artist
Marilena Greig
Philanthropist and Volunteer
Thomas M. Rashid MD
Physician
Daisy Fuentes
Shelter Entertainment
Nicholas Buttafuoco
Buttafuoco, Arce & Price
Randa Fahmy Hudome
Fahmy Hudome International LLC
Gary J. Rotella
Gary J. Rotella & Associates PA
Don Germano
DICK’s Sporting Goods
Martha Byrne
Actress
Lawrence K. Jensen
Commercial Advisors LLC
Andrew San Marco
Tradition
Greg Gumbel
Sportscaster
Nick Caporella
National Beverage Corp.
Linda Johansen-James
American Kiosk Management LLC
Jack Soden
Elvis Presley Enterprises Inc.
George Joulwan
General (Retired)
Terri Carr
Wisteria Fashions
Andy Kelly
LEDIC Management Group
Gary B. Stone
Univision Radio
J. David Karam
Cedar Enterprises
Cari Cook
Delta Delta Delta
Margo R. Keyes
Key Development LLC
John L. Strauss
The John and Bonnie Strauss Foundation
Erik Logan
OWN, The Oprah Winfrey Network
Robert J. “Bob” Corliss
CorlissMoore
Eunice Mazloom
Philanthropist and Volunteer
Arnold “Arnie” I. Schwartzman
Arent Fox LLP
Michael J. Lynch
Bank of America Merrill Lynch
Jacqueline Corso
Philanthropist
Bryce McTavish
MillerCoors
John Tanner
U.S. House of Representatives (former)
Maguy Maccario
Consulate General of Monaco
Chaz Corzine
The MWS Group
Lattimore M. Michael
Back Yard Burgers, Inc.
Peter J. Tanous
Lepercq Lynx Investment Advisory
T. Allan McArtor
Airbus North America Holdings Inc.
Trish Coury
Lakeview Village Corporation
William N. Morris, Jr.
The Morris Group
Amber Valletta
Model/Actress
Joe Theismann
JRT Associates Inc.
Joseph K. DeLapp II
Visioneering Technologies, Inc.
Jerry D. Neal
RF Micro Devices
Mac Winker
The Racquet Club of Memphis (former)
Marty Belz
Peabody Hotel Group
Richard A. Abdoo
Eric Trump
Wisconsin Energy Corporation (retired)
Trump Organization
Doug Brooks
Brinker International
Russell Weiner
Domino’s Pizza
Joe DeVivo
AngioCynamics Inc.
Buell G. Duncan III
IBM Software Group
Reagan | at age 3
COMMITTED TO THE CHILDREN
acute lymphoblastic leukemia
ST. JUDE AND ALSAC
LEADERSHIP
Kimberly Ovitt
Senior Vice President
Chief Communications Officer
Sean Phipps, PhD
Chair, Behavorial Medicine
Ching-Hon Pui, MD
Chair, Oncology
ST. JUDE EXECUTIVE COMMITTEE
Emily Greer
Chief Administrative Officer
Sara Hall
Chief Legal Officer
Douglas Green, PhD
Chair, Immunology
Mary Relling, PharmD
Chair, Pharmaceutical Sciences
Robert Machen
Chief Information Officer
Mike Canarios
Senior Vice President
Chief Financial Officer
Gerard Grosveld, PhD
Chair, Genetics
Raul Ribeiro, MD
Director, International Outreach Program
Jeffrey T. Pearson
Chief Financial Officer
Andrew M. Davidoff, MD
Chair, Surgery
Kip Guy, PhD
Chair, Chemical Biology and Therapeutics
Les Robison, PhD
Chair, Epidemiology and Cancer Control
William Reeser
Chief Investment Officer
Robyn Diaz, JD
Interim Chief Legal Officer and
General Counsel
James Ihle, PhD
Chair, Biochemistry
Charles Sherr, MD, PhD
Chair, Tumor Cell Biology
George P. Shadroui
Chief Strategy Officer
Larry Kun, MD
Executive Vice President
Clinical Director
Chair, Radiological Sciences
Elaine Tuomanen, MD
Chair, Infectious Diseases
Pat Wyatt
Chief Development Officer
Stephen White, PhD
Chair, Structural Biology
SENIOR VICE PRESIDENTS
Peter Doherty, PhD
Nobel Laureate, Immunology
Pam Dotson, RN, MBA
Senior Vice President
Patient Care Services and Chief Nursing Officer
James Downing, MD
Executive Vice President
Scientific Director
Deputy Director
David W. Ellison, MD, PhD, MRCP (UK)
Chair, Pathology
Amar Gajjar, MD
Co-Chair, Oncology
Chair, Pediatric Medicine
PAGE 50
Emily Callahan
Chief Marketing Officer
Mary Anna Quinn
Senior Vice President
Chief Operations and Support Officer
James Boyett, PhD
Chair, Biostatistics
|
Richard Shadyac Jr.
Chief Executive Officer
Richard Gilbertson, MD, PhD
Executive Vice President
Director, Comprehensive Cancer Center
Dr. William Evans
Director and Chief Executive Officer
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
ALSAC EXECUTIVE
LEADERSHIP TEAM
Wing Leung, MD
Chair, Bone Marrow Transplantation and
Cellular Therapy
Thomas Merchant, DO, PhD
Chair, Medical Executive Committee
James Morgan, PhD
Chair, Developmental Neurobiology
Clayton Naeve, PhD
Senior Vice President
Chief Information Officer
Christopher Boysen
Field Operations
Steven Froehlich
National Direct Marketing
Melanee Hannock
Marketing/iGroup
Sue Harpole
Gift Planning
Karen White
Strategic Partnerships
VICE PRESIDENTS
Brenda Abshure
Executive Projects
Wilfred Busby
Call Centers
Nila Carrington
Human Resources
Jennifer Haslip
Communications
Sherry Lear-Park
Donor Care
Betty MacDougall
CEO Affairs and
Executive Communication
Cecilia Villa
Executive Director
International Partnerships
“When we came to
St. Jude, we were in
the position of
losing a child, of
being victimized by
cancer. But now we
are with our son,
with our children,
happy and hopeful.”
– Mary Cecile
Mother of St. Jude patient Anthony Lawrence
age 8
ependymoma
ALSAC/ST. JUDE CHILDREN’S RESEARCH HOSPITAL
COMBINED FINANCIAL HIGHLIGHTS FOR FISCAL YEAR 2012
Dionisio | at age 2
acute lymphoblastic leukemia
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 52
YEARS ENDED JUNE 30 (IN THOUSANDS) 20122011
REVENUES
Total Support$805,670 $728,656
Net Patient Service Revenue95,537 88,718
Research Grants95,190 101,488
Net Investment Income(26,055)337,307
Other8,636 9,125
TOTAL REVENUES978,978 1,265,294
EXPENSES
Program Expenses
Patient Care Services289,490265,713
Research309,832299,348
Education, Training and Community Support71,52459,504
TOTAL PROGRAM EXPENSES670,846624,565
Fundraising143,086143,788
Administrative and General86,92178,428
TOTAL EXPENSES900,853846,781
GAIN (LOSS) ON DISPOSAL OF PROPERTY AND EQUIPMENT(2,008)(144)
CHANGE IN NET ASSETS76,117418,369
BEGINNING NET ASSETS2,541,6392,123,270
ENDING NET ASSETS 2,617,7562,541,639
JOIN US
St. Jude will never stop looking for the
cures that save children’s lives. That was
our founder’s promise and that is our
commitment today. You can help St. Jude
give hope to children fighting cancer and
other deadly diseases and ensure that no
family ever pays St. Jude for anything.
Kayla | at age 8
Visit stjude.org today to help.
acute lymphoblastic leukemia
THERE IS ONLY ONE ST. JUDE 2012 ANNUAL REPORT
|
PAGE 54
©2013 ALSAC/St. Jude Children’s Research Hospital (12726)